Advertisement

Weibull function fits to pharmacokinetic data of ribavirin in man

  • X. D. Liu
  • L. Xie
  • K. Q. Han
  • G. Q. Liu
Article

Summary

Weibull function C=Bts−1exp(−λts) was used to describe plasma concentration-time data of ribavirin in 6 healthy subjects following an i.v. dose of 600 mg. A good fit was found in each of the subjects, where the coefficients of determination r2 were > 0.99. The parameters estimated were as follows: B, 5.90 ± 1.86 μg.h1−s; λ, 0.607 ± 0.156 h−s; and s, 0.339 ± 0.085, respectively. The results were compared with those by triexponential function. By providing lower values of AIC and SD, as well as higher values of r2, the Weibull function proved to be superior to triexponential function for data of 3 subjects. These results indicated that both Weibull function and triexponential function provided a good fit of plasma concentration-time data of ribavirin in man following an i.v. dose.

Keywords

Weibull function pharmacokinetics ribavirin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Huffman J.H., et al. (1973): In vitro effect of 1-β-d-ribofuranosyl-1,2,4,-triazole-3-carboxamide on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob. Agents Chemother., 3, 235–241.PubMedGoogle Scholar
  2. 2.
    Sidwell R.W., et al. (1972): Broad-spectrum antiviral activity of virazole: 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science, 177, 705–706.CrossRefPubMedGoogle Scholar
  3. 3.
    Laskin O.L., et al. (1987): Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. Clin. Pharmacol. Ther., 419, 546–555.Google Scholar
  4. 4.
    Pitrovskii V.K. (1987): Pharmacokinetic stochastic model with Weibull distributed residence times of the drug molecules in the body. Eur. J. Clin. Pharmacol., 32, 515–523.CrossRefGoogle Scholar
  5. 5.
    Granich G.C., et al. (1989): High performance liquid chromatography assay for ribavirin and comparison of the HPLC assay with radioimmunoassay. Antimicrob. Agents Chemother., 33, 311–115.PubMedGoogle Scholar
  6. 6.
    Yang Y.C., et al. (1983): A non-linear method and its program for calculating pharmacokinetic parameters. Acta Pharmacol. Sin., 4, 220–225.Google Scholar
  7. 7.
    Zeng Y.L. (1980): Two aspects about curve fitting in pharmacokinetics: weighting of experimental data and discrimination between linear compartmental model. Acta Pharm. Sin., 15, 571–576.Google Scholar
  8. 8.
    Yamaoka K., et al. (1978): Application of Akaike’s information criterion in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm., 6, 165–175.CrossRefPubMedGoogle Scholar

Copyright information

© Médecine et Hygiène 1994

Authors and Affiliations

  • X. D. Liu
    • 1
  • L. Xie
    • 1
  • K. Q. Han
    • 1
  • G. Q. Liu
    • 1
  1. 1.Department of Metabolism and PharmacokineticsChina Pharmaceutical UniversityNanjing, Jiangsu ProvincePeople’s Republic of China

Personalised recommendations